An Alternative Dosing Schedule of Varenicline for Smoking Cessation

Phase 2 Completed 60 enrolled Roswell Park Cancer Institute Pfizer · collab

RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to explore the use of an prolonged alternative dosing schedule using varenicline for smoking cessation leading to greater quit rates and higher rates of continuous abstinence.

Timeline

Start: 2009-03
Primary completion: 2010-07
Completion: 2015-07

Publications

Livingstone-Banks J, Fanshawe TR, Thomas KH, Theodoulou A, Hajizadeh A, Hartman L, Lindson N. Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev. 2023 May 5;5(5):CD006103. doi: 10.1002/14651858.CD006103.pub8.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Varenicline	Small molecule	—	—

Indications

No indication recorded.